The LRP6 co-receptor is also overexpressed in other tumors (colorectal, liver, and pancreatic cancers) and reducing LRP6 expression in these tumors, as well as in breast cancers, was proposed as a strategy for inhibiting tumor cell growth [417]. Here, LRP6 is linked to neoplasm.